NSC31150 is primarily utilized in research settings to study its potential as an anticancer agent. It has been investigated for its ability to inhibit specific cellular pathways involved in tumor growth and proliferation. Researchers explore its efficacy in targeting cancer cells while minimizing damage to healthy tissues, making it a candidate for further development in chemotherapy. Additionally, NSC31150 is used in preclinical studies to understand its mechanisms of action and to assess its pharmacokinetics and toxicity profiles. These studies aim to determine its suitability for clinical trials and potential use in cancer treatment regimens.